Sign up
Pharma Capital

First myLotus sales order 'the key milestone' so far for Concepta - CEO Erik Henau

Erik Henau, chief executive of Concepta PLC (LON:CPT) tells Proactive they've received a first sales order for their myLotus fertility products.

The order – from HuanZhong Biotech, Concepta’s partner in China – is worth £225,000 (RMB 1.95mln).

Once Concepta has fulfilled the order, HZ Biotech will distribute the myLotus products in China.

 

View full CPT profile

Concepta Timeline

View All

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.